Paths to Myasthenia Gravis Treatment: Choosing Between Traditional and Minimally Invasive Surgery

Myasthenia Gravis: Is Minimally Invasive Surgery Right for You?

Elliot Brynn monogram
Elliot Brynn in Health & Wellness October 2026 • 4 min read.

"Explore the Latest Research on Minimally Invasive Approaches for Treating Non-Thymomatous Myasthenia Gravis and Make an Informed Decision About Your Health"


Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body. While there's no cure, various treatments can help manage symptoms, allowing individuals to lead fulfilling lives. Traditional treatments often include medications and, in some cases, surgery, particularly thymectomy (removal of the thymus gland).

Traditionally, thymectomy was performed via complete sternotomy, a procedure involving a large incision down the center of the chest. While effective, this approach can result in significant post-operative pain, a lengthy recovery period, and noticeable scarring. In recent years, minimally invasive surgical techniques have emerged as alternatives, aiming to reduce these drawbacks.

These newer methods, such as video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracic surgery (RATS), involve smaller incisions, potentially leading to less pain, quicker recovery, and improved cosmetic results. However, questions remain about whether these minimally invasive approaches are as effective as traditional sternotomy for all patients with MG.

AI Search Multiple angles on this topic

Evidence on Minimally Invasive Thymectomy

ClinicalTrials.gov study NCT04158661 is investigating whether minimally invasive thymectomy achieves efficacy and safety comparable to open thymectomy in people with myasthenia gravis. A 2026 PubMed study evaluates feasibility and outcomes after a thoracic surgery unit transitioned from sternotomy to minimally invasive surgery, including MG Composite and MG-ADL scores. A separate review notes that the best surgical approach remains debated and describes minimally invasive surgery as potentially offering lower mortality and morbidity, improved cosmetic results, and equivalent efficacy.

Open and Minimally Invasive Options

Open thymectomy can be performed through transsternal or transcervical approaches, while minimally invasive options include video-assisted thoracoscopic surgery (VATS) and robotic surgery through small incisions. These approaches differ in surgical exposure of thymic tissue and their ability to perform extracapsular dissection. Research has compared minimally invasive thymectomy with the trans-sternal approach in non-thymomatous myasthenia gravis, examining whether similar neuromuscular benefits are achieved. The available sources frame the choice of approach as an active subject of study rather than establishing one method as universally superior.

Milestones in Myasthenia Gravis

Thomas Willis provided the first clinical description of myasthenia gravis in 1672 in *De Anima Brutorum*. Treatment remained negligible until Mary Walker observed improvement with physostigmine and neostigmine injections in 1934. Blalock reported initial success with thymectomy around 1940; edrophonium followed around 1950, and pyridostigmine was introduced in the mid-1950s. A 2019 review describes the last 15 years as a particularly active period for clinical trials in MG.

Minimally Invasive vs. Traditional Thymectomy: What Does the Research Say?

Paths to Myasthenia Gravis Treatment: Choosing Between Traditional and Minimally Invasive Surgery

A research study published in Abstracts/Interactive CardioVascular and Thoracic Surgery, investigated the clinical outcomes of minimally invasive surgical approaches compared to the traditional cervicotomy with upper sternotomy (C-US) for non-thymomatous MG. The study, titled "Minimally Invasive Surgical Approaches for the Treatment of Non-Thymomatous Myasthenia Gravis: A Comparative Propensity-Score Adjusted Multicentre Study," aimed to provide insights into the effectiveness and safety of these different surgical techniques.

The study involved a retrospective analysis of 267 patients with non-thymomatous MG who underwent surgery at two European thoracic surgery centers between 1990 and 2015. The researchers compared the outcomes of patients who underwent C-US, VATS, and RATS, focusing on key indicators such as remission rate, improvement in Myasthenia Gravis Foundation of America (MGFA) clinical status, and reduction or suspension of steroid treatment.

  • Cervicotomy with Upper Sternotomy (C-US): This traditional approach involves an incision in the neck combined with a partial split of the sternum (breastbone).
  • Video-Assisted Thoracoscopic Surgery (VATS): VATS is a minimally invasive technique that uses small incisions and a video camera to guide the surgeon.
  • Robot-Assisted Thoracic Surgery (RATS): RATS is another minimally invasive approach that utilizes a surgical robot to enhance precision and control during the procedure.
AI Search Multiple angles on this topic

Uni-Portal Video-Assisted Thymectomy

A PubMed article published July 17, 2026, titled “Improving outcomes in myasthenia gravis: uni-portal video ...,” examines uni-portal video-assisted thymectomy. Its abstract describes thymectomy as a well-established treatment for myasthenia gravis and notes that minimally invasive approaches are increasingly preferred because of reduced morbidity. The source snippet does not provide study results or further details about the approach, so it does not establish specific outcome improvements for uni-portal surgery.

The results of the study indicated that there was no significant difference in remission rate or improvement of MGFA clinical status between the minimally invasive approaches (RATS/VATS) and the traditional C-US method. Specifically, the study found that MGFA clinical-status improved in 89% (186/209) of the patients and remission of symptoms was observed in 42% (87/209). Furthermore, 47% (32/68) of patients were able to suspend/reduce steroid treatment. The research suggests that RATS/VATS had similar clinical outcomes compared to C-US.

Making an Informed Decision: Discussing Surgical Options with Your Doctor

If you're living with non-thymomatous Myasthenia Gravis, it's essential to discuss all available treatment options with your healthcare team. Minimally invasive surgical techniques like VATS and RATS offer potential benefits, such as reduced pain and quicker recovery. While research suggests these approaches are comparable to traditional methods in terms of clinical outcomes, the best choice depends on individual factors, including your overall health, preferences, and the expertise available at your medical center. This information can empower you to have a more informed discussion with your doctor, leading to the best possible care plan for your unique needs.

AI Search Multiple angles on this topic

Evidence Behind Surgery for MG

A narrative review of surgery for myasthenia gravis explains that, up until the last decade, evidence suggesting benefit from thymectomy was based on non-randomized controlled studies. The review presents itself as an expert discussion of newer literature on surgical management. This places interpretation of thymectomy evidence in the context of how the underlying studies have developed.

Building Evidence for Newer Techniques

A 2025 review says real-world data should help clarify remission rates and the risk of thymoma recurrence associated with novel minimally invasive techniques, and calls for prospective studies where possible. A 2026 review describes robotic-assisted thymectomy as a well-established option for acetylcholine receptor-positive MG and highlights the da Vinci system among the platforms discussed. Together, these sources point to continued evaluation of outcomes and evidence gaps as minimally invasive and robotic approaches develop.

VATS compared with transsternal surgery

  • −1.233 standardized mean differenceVATS was associated with less blood loss than transsternal surgery, with a standardized mean difference of −1.233 (95% CI −1.425 to −1.041).[1]

What these thymectomy comparisons add up to

The reported VATS comparisons favor it on some measures of surgical burden, but those measures do not establish that its neuromuscular effects are better. The robotic follow-up also shows that remission and broader improvement are distinct outcomes, rather than interchangeable descriptions of recovery.[1] [2]

Across open and minimally invasive approaches, remission comparisons at several follow-up points did not show a statistical difference. That is evidence of no detected difference in those comparisons, not proof that the approaches are identical.[3]

Where surgical exposure and outcome evidence differ

The approaches also differ in how well they expose tissue: a thoracoscopic transthoracic route may make the opposite-side phrenic nerve and mediastinal fat harder to expose, while a subxiphoid route can expose both sides. The stated goal across surgical methods is to remove as much thymic tissue as possible while preserving specified nerves.[4] [5]

A concern raised for VATS and robotic surgery is residual thymic tissue; results from an extended transsternal operation may not transfer directly to minimally invasive methods that avoid median sternotomy. The cited discussion calls for well-designed observational comparisons, and another analysis says the role of minimally invasive thymectomy remains controversial without a randomized trial that includes these newer approaches.[2] [5]

What remains unresolved about minimally invasive thymectomy

  • Do minimally invasive operations remove thymic tissue as completely as extended transsternal surgery, given the concern about residual tissue and differences in exposure?[4] [5]
  • Would a randomized comparison that includes newer approaches clarify whether their clinical results match those of open surgery?[2] [5]

Sources

  1. Sternotomy versus video-assisted thoracoscopic surgery for thymectomy of myasthenia gravis patients: A meta-analysis. (pubmed.ncbi.nlm.nih.gov)
  2. Robotic Thymectomy for Myasthenia Gravis: Analysis of the Surgical and Neurological Outcomes After a 20 Years' Experience (pmc.ncbi.nlm.nih.gov)
  3. The short and long-term effects of open vs minimally invasive thymectomy in myasthenia gravis patients: a systematic review and meta-analysis. (pubmed.ncbi.nlm.nih.gov)
  4. Which is the best surgical approach for thymectomy: robot-assisted thoracoscopic surgery (RATS), video-assisted thoracoscopic surgery (VATS), thoracotomy (TORA) or subxiphoid video-assisted thoracosco (pmc.ncbi.nlm.nih.gov)
  5. ("bell palsy"[MeSH Terms] OR ("bell"[All Fields] AND "palsy"[All Fields]) OR "bell palsy"[All Fields] OR ("bell's"[All Fields] AND "palsy"[All Fields]) OR "bell's palsy"[All Fields]) AND ((clinical[Ti (www.aan.com)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is Myasthenia Gravis, and what does it do?

Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disease. It causes weakness in the skeletal muscles, which are responsible for movement and breathing. While there's no cure, various treatments help manage symptoms, allowing individuals to lead fulfilling lives. The disease's impact stems from the body's immune system mistakenly attacking the communication between nerves and muscles, causing debilitating muscle weakness.

2

What are the benefits of minimally invasive surgical techniques like VATS and RATS?

Minimally invasive surgical techniques, such as Video-Assisted Thoracoscopic Surgery (VATS) and Robot-Assisted Thoracic Surgery (RATS), offer alternatives to traditional methods like Cervicotomy with Upper Sternotomy (C-US). These approaches use smaller incisions, potentially leading to less pain, quicker recovery, and improved cosmetic results. Their significance lies in the potential to improve patient experience and reduce the drawbacks associated with the more invasive C-US method. The implications include a shift towards less invasive procedures for treating Myasthenia Gravis, enhancing recovery and potentially improving overall quality of life.

3

What is Cervicotomy with Upper Sternotomy (C-US), and why is it important?

Cervicotomy with Upper Sternotomy (C-US) is a traditional surgical approach involving an incision in the neck combined with a partial split of the sternum (breastbone). It's been a standard method for procedures like thymectomy in treating Myasthenia Gravis. Its importance is in its historical use and established effectiveness. Implications include significant post-operative pain, a lengthy recovery period, and noticeable scarring, prompting the development of less invasive techniques such as VATS and RATS.

4

How do Video-Assisted Thoracoscopic Surgery (VATS) and Robot-Assisted Thoracic Surgery (RATS) work?

Video-Assisted Thoracoscopic Surgery (VATS) and Robot-Assisted Thoracic Surgery (RATS) are minimally invasive techniques used in treating Myasthenia Gravis. VATS uses small incisions and a video camera to guide the surgeon, while RATS utilizes a surgical robot to enhance precision and control. These methods are significant because they aim to reduce the drawbacks of traditional approaches like C-US, potentially leading to less pain, quicker recovery, and better cosmetic outcomes. The implication is a shift toward less invasive procedures, potentially improving patient outcomes and experience.

5

What were the key findings of the research comparing VATS, RATS, and C-US for Myasthenia Gravis?

The research study compared the clinical outcomes of minimally invasive surgical approaches (VATS and RATS) to the traditional Cervicotomy with Upper Sternotomy (C-US) for non-thymomatous Myasthenia Gravis. The study's importance is in providing insights into the effectiveness and safety of different surgical techniques. The implications are that the study found similar clinical outcomes between RATS/VATS and C-US, with no significant differences in remission rates or improvement in Myasthenia Gravis Foundation of America (MGFA) clinical status, which helps patients and doctors make informed decisions about treatment options.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.